Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
輝瑞公司——預計與多年成本調整工作相關的成本將持續到2024年,總額約爲28億美元
Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
輝瑞公司——預計與多年成本調整工作相關的成本將持續到2024年,總額約爲28億美元
使用瀏覽器的分享功能,分享給你的好友吧